MARKET WIREReuters • 3h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
Why STAA Stock surged +2.56% Today — RQD Quant Desk Flash
$25.24 +2.56% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $25.31
STAAR Surgical Company (STAA) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $1.27B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on STAA Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is STAA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, STAAR Surgical Company (NASDAQ: STAA) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $25.24 (+2.56% 1D, market cap $1.27B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, STAA ranks #700 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does STAA compare to EYE and WRBY in the Health Care sector?
▼
Within the Health Care sector (Ophthalmic Goods), STAA carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 76.2%, and ROIC of -35.0%. By comparison, EYE (National Vision Holdings Inc.) holds a C+ grade (68/100 RQD, P/E 44.4x, ROIC 4.4%, cap $1.32B) and WRBY (Warby Parker Inc.) posts a D+ grade (52/100 RQD, P/E N/A, ROIC -1.7%, cap $3.04B). Among the 5-stock peer group, EYE leads on earnings multiple (44.4x) while EYE leads on capital efficiency (4.4% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for STAA?
▼
Per STAA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-02, CIK 0000718937), STAAR Surgical Company generated $239.4M in revenue (-23.7% YoY), -$80.4M in net income, and -$40.0M in free cash flow against $451.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $25.31 (+0.27%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-9% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for STAA)Realized 20D OHLCV Swing Band: ±8.5%
Deterministic 5-Pillar Attribution (38/100 Composite)
🔍 WHY STAA SCORES 38/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (29% of score)
Altman Z-Score 7.11 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9
▲ #2 Bullish Driver: Whale & Options Positioning+10/20 pts (26% of score)
20D Institutional Volume Accumulation (±8.5% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$21.67-1.8% Next Q
30
Q2 (-2Q)Grade E$21.27+6.3% Next Q
33
Q3 (-1Q)Grade E$22.61+11.6% Next Q
35
CurrentGrade D-$25.24-7.8% Hist 90D α
38
Trajectory: E (30) → D- (38)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a STAA Turnaround Squeeze
While STAA currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($22.42) and Max Pain ($26.50) forces dealer call-delta covering toward $37.66.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $STAA• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “STAA Beats Next Quarter EPS Consensus (Jan 1, 2027) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why STAA Stock surged +2.56% Today — RQD Quant Desk Flash
STAAR Surgical Company (STAA) surged +2.56% to $25.24, trading at 48% of its 52-week range ($15.59 – $35.87). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 48% of its 52-week range ($15.59 – $35.87) with RSI-14 at 61.8 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.5% around $25.24 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 76.2% gross margin and $0 annual free cash flow.
Live STAA Headlines & Catalysts
MARKET WIREReuters • 3h ago
Oil slips more than 1% as talks continue on ending Iran war - ReutersOil slips more than 1% as talks continue on ending Iran war Reuters
MARKET WIREReuters • 4h ago
Nine people dead in Learjet crash in south Florida, officials say - ReutersNine people dead in Learjet crash in south Florida, officials say Reuters
MARKET WIREReuters • 6h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
MARKET WIRECNBC • 8h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 8h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 10h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 11h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring STAA)
- ✓Walkthrough of STAA's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
STAA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -4.25%▲ RESISTANCE BREAKOUT
2026-10-30O $25.00H $25.42L $24.32C $25.24VOL 535.5K
RES: $20.88SUP: $17.69SMA50: $22.42SMA200: $23.60
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
STAA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -23.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on STAA today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for STAA. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for STAA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (STAA)
Health Care Rank #700 of 1016
⚔️ EYE vs STAA Full Matrix →
1. Head-to-Head Health Care Peer Comparison (STAA vs. EYE, WRBY, BLCO, RXST)
Industry: Ophthalmic Goods (8 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, STAAR Surgical Company (STAA) ranks #700 by composite RQD confidence (38/100, grade D-) and #329 by equity capitalization ($1.27B). Within this direct 5-issuer industry benchmark cohort, EYE leads on earnings valuation at 44.4x trailing P/E, while EYE leads on capital efficiency and profitability with 4.4% ROIC and — gross margin. EYE currently holds the highest overall quantitative score in the immediate peer group at 68/100 (C+) compared with STAA at 38/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| STAA
ACTIVE
STAAR Surgical Company | D- | 38/100 | — | 76.2% | -35.0% | +2.56% | $1.27B | Benchmark Subject |
| EYE National Vision Holdings Inc. | C+ | 68/100 | 44.4x | — | 4.4% | +7.63% | $1.32B | /eye-vs-staa → |
| WRBY Warby Parker Inc. | D+ | 52/100 | — | 54.0% | -1.7% | +0.66% | $3.04B | /wrby-vs-staa → |
| BLCO Bausch + Lomb Corporation | D- | 42/100 | — | — | 0.8% | 0.00% | $7.29B | /blco-vs-staa → |
| RXST RxSight Inc. | D- | 35/100 | — | 76.6% | -14.9% | +3.06% | $210.0M | /rxst-vs-staa → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-01-02 • CIK 0000718937In its most recent audited fiscal period (FY2025, filed 2026-01-02), STAAR Surgical Company (STAA) reported GAAP revenue of $239.4M (-23.7% vs. FY2024 revenue of $313.9M , and -25.7% cumulative change since FY2023) , GAAP net income of -$80.4M, operating cash flow of -$34.2M, and free cash flow of -$40.0M (-422.2% YoY). On the balance sheet, STAA closed FY2025 with $451.7M in total assets against $0 in total debt (Altman Z-Score: 7.11, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-01-02 | $239.4M | -$80.4M | -$34.2M | -$40.0M | $451.7M | — |
| FY2024 (FY) | 2024-12-27 | $313.9M | -$20.2M | $15.7M | -$7.7M | $509.5M | — |
| FY2023 (FY) | 2023-12-29 | $322.4M | $21.3M | $14.6M | $14.6M | — | — |
3. STAA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs STAA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, STAAR Surgical Company (NASDAQ: STAA) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $25.24 (+2.56% 1D, market cap $1.27B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, STAA ranks #700 in composite RQD confidence.
How does STAA compare to EYE and WRBY in the Health Care sector?
Within the Health Care sector (Ophthalmic Goods), STAA carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 76.2%, and ROIC of -35.0%. By comparison, EYE (National Vision Holdings Inc.) holds a C+ grade (68/100 RQD, P/E 44.4x, ROIC 4.4%, cap $1.32B) and WRBY (Warby Parker Inc.) posts a D+ grade (52/100 RQD, P/E N/A, ROIC -1.7%, cap $3.04B). Among the 5-stock peer group, EYE leads on earnings multiple (44.4x) while EYE leads on capital efficiency (4.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for STAA?
Per STAA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-02, CIK 0000718937), STAAR Surgical Company generated $239.4M in revenue (-23.7% YoY), -$80.4M in net income, and -$40.0M in free cash flow against $451.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is STAA trading relative to its 50-day, 200-day, and 52-week technical levels?
STAA last traded at $25.24 (+2.56% on volume of 454,652 shares), positioning the stock +12.58% above its 50-day simple moving average ($22.42) and +6.95% above its 200-day simple moving average ($23.60). Across its 52-week range of $15.59 to $35.87, STAA sits at the 47.6% percentile with a 14-day RSI of 61.8 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.5% ($23.09 to $27.39).
STAA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is STAA stock moving today?
Why STAA Stock surged +2.56% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.